Novel congenital myasthenic syndromes associated with defects in quantal release

Neurology

Volumn 66, Issue 8, 2006, Pages 1223-1229

  Milone, M ^a   Fukuda, T ^a   Shen, X M ^a   Tsujino, A ^a   Brengman, J ^a   Engel, A G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN I 125; CHOLINERGIC RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CONGENITAL MYASTHENIC SYNDROME; ELECTROMYOGRAM; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MICROELECTRODE; PATCH CLAMP; PRIORITY JOURNAL; SYNAPSE; SYNAPSE VESICLE; WHEELCHAIR;

ACETYLCHOLINESTERASE; CHILD; EVOKED POTENTIALS; HUMANS; MALE; MIDDLE AGED; MOTOR ENDPLATE; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; NERVE DEGENERATION; PRESYNAPTIC TERMINALS; PROTEIN CONFORMATION; RECEPTORS, CHOLINERGIC; SYNAPTIC VESICLES;

EID: 33646696195     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000205596.19540.2c     Document Type: Article

References (50)

1. Engel AG, Sine SM. Current understanding of congenital myasthenic syndromes. Cur Opin Pharmacol 2005;5:306-321.
2. Bady B, Chauplannaz G, Carrier H. Congenital Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1987;50:476-478.
3. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: progress over the past decade. Muscle Nerve 2003;27:4-25.
4. Walls TJ, Engel AG, Nagel AS, Harper CM, Trastek VF. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann NY Acad Sci 1993;681:461-468.
5. Maselli RA, Kong DZ, Bowe CM, et al. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology 2001;57:279-289.
6. Ohno K, Tsujino A, Brengman JM, et al. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 2001;98:2017-2022.
7. Lambert EH, Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 1971;183:183-199.
8. Maselli RA, Books W, Dunne V. Effect of inherited abnormalities of calcium regulation on human neuromuscular transmission. Ann NY Acad Sci 2003;998:18-28.
9. Fambrough DM, Engel AG, Rosenberry TL. Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1982;79:1078-1082.
10. Gautron J. Cytochimie ultrastructurale des acétylcholinesté rases. Microscopie 1974;21:259-264.
11. Engel AG. The muscle biopsy. In: Engel AG, Franzini-Armstrong C, eds. Myology. 3rd ed. New York: McGraw-Hill, 2004:681-690.
12. Engel AG. Quantitative morphological studies of muscle. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1018-1045.
13. Engel AG, Lindstrom JM, Lambert EH, Lennon VA. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology 1977;27:307-315.
14. Engel AG, Uchitel O, Walls TJ, Nagel A, Harper CM, Bodensteiner JB. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel. Ann Neurol 1993;34:38-47.
15. Milone M, Hutchinson DO, Engel AG. Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate. Muscle Nerve 1994;17:1364-1369.
16. Chen YA, Scales SJ, Scheller RH. Sequential SNARE assembly underlies priming and triggering of exocytosis. Neuron 2001;30:161-170.
17. Fernandez-Chacon R, Königstorfer A, Gerber SH, et al. Synaptotagmin I functions as a calcium regulator of release probability. Nature 2001;410:41-49.
18. 2+-triggered exocytosis. Neuron 2002;34:599-611.
19. Yoshihara M, Littleton JT. Synaptotagmin functions as a calcium sensor to synchronize neurotransmitter release. Neuron 2002;36:897-908.
20. Hu K, Carroll J, Fedorovich S, Rickman C, Sukhodub A, Davletov BA. Vesicular restriction suggests a role for calcium in membrane fusion. Nature 2000;415:646-650.
21. Tanaka M, Miyoshi J, Ishizaki H, et al. Role of Rab3 GDP/GTP exchange protein in synaptic vesicle trafficking at the mouse neuromuscular junction. Molec Biol Cell 2001;12:1421-1430.
22. Martin TFJ. Prime movers of synaptic vesicle exocytosis. Neuron 2003;34:9-12.
23. Pevsner J, Hsu SC, Braun JE, et al. Specificity and regulation of a synaptic vesicle docking complex. Neuron 1994;13:353-361.
24. Verhage M, Maia AS, Plomp JJ, et al. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 2000;287:864-869.
25. Weimer RM, Richmond JE, Davis WS, Hadwiger G, Nonet ML, Jorgensen EM. Defects in synaptic vesicle docking in unc-18 mutants. Nat Neurosci 2003;6:1023-1030.
26. Xu T, Bajjalieh SM. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nature Cell Biol 2001;3:691-698.
27. Sokolow S, Manto M, Gailly P, et al. Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3. J Clin Invest 2004;113:265-273.
28. 2+/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3. J Cell Biol 2000;149:783-792.
29. Sudhof TC. The structure of the human synapsin I gene and protein. J Biol Chem 1990;265:7849-7852.
30. Valtorta F, Benfenati F, Greengard P. Structure and function of the synapsins. J Biol Chem 1992;267:7195-7198.
31. Polo-Parada L, Bose CM, Landmesser LT. Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions. Neuron 2001;32:815-828.
32. Polo-Parada L, Bose CM, Plattner F, Landmesser LT. Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180 kDa isoform-deficient mice. J Neurosci 2004;24:1852-1864.
33. Polo-Parada L, Plattner F, Bose C, Landmesser LT. NCAM 180 acting via a conserved C-terminal domain and MLCK is essential for effective transmission with repetitive stimulation. Neuron 2005;46:917-931.
34. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin β2. Nature 1995;374:258-262.
35. Knight D, Tolley LK, Kim DK, Lavidis NA, Noakes PG. Functional analysis of neurotransmission at β2-laminin deficient terminals. J Physiol (Lond) 2003;546:789-800.
36. Nishimune H, Sanes JR, Carlson SS. A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 2004;432:580-587.
37. Engel AG, Lambert EH, Gomez MR. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1977;1:315-330.
38. Engel AG, Lambert EH, Mulder DM, et al. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982;11:553-569.
39. Milone M, Wang H-L, Ohno K, et al. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 1997;17:5651-5665.
40. Pennefather P, Quastel DMJ. Relation between subsynaptic receptor blockade and response to quantal transmitter at the mouse neuromuscular junction. J Gen Physiol 1981;78:313-344.
41. Garner CC, Zhai RG, Gundelfinger ED, Ziv NE. Molecular mechanisms of CNS synaptogenesis. Trends Neurosci 2002;25:243-251.
42. Aguado F, Majo G, Ruiz-Montasell B, Llorens J, Marsal J, Blasi J. Syntaxin 1A and B display distinct distribution patterns in the rat peripheral nervous system. Neuroscience 1999;88:437-446.
43. Marz KE, Hanson PI. Sealed with a twist: complexin and the synaptic SNARE complex. Trends Neurosci 2002;25:381-383.
44. Chen X, Tomchick DR, Kovrigin E, et al. Three-dimensional structure of the complexin/SNARE complex. Neuron 2002;33:397-409.
45. 2+-dependent exocytosis: dynamic action in a flash. Neuron 2003;38:521-524.
46. Chamberlain LH, Burgoyne RD. Cysteine-string protein: the chaperone at the synapse. J Neurochem 2000;74:1781-1789.
47. Fernandez-Chacon R, Wolfel M, Nishimune H, et al. The synaptic vesicle protein CSPα prevents presynaptic degeneration. Neuron 2005;42:237-251.
48. Mori Y, Friedrich T, Kim MS, et al. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 1991;350:398-402.
49. Downes GB, Granato M. Acetylcholinesterase function is dispensable for sensory neurite growth but is critical for neuromuscular junction stability. Dev Biol 2004;270:232-245.
50. Sharma KV, Koenigsberger C, Brimijoin S, Bigbee JW. Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth. J Neurosci Res 2001;63:165-175.